First Patient Active with Latitude NXT Remote Patient Management System
June 15, 2012 — Boston Scientific Corp. has initiated use of the Latitude NXT Remote Patient Management System with patients who have implantable electrophysiology devices in Europe.
Dr. Roberto Verlato, head of cardiology at Camposampiero Hospital in Verona, Italy initiated use of the Latitude NXT system with a patient implanted with an Ingenio SR pacemaker, and provided the patient with a new home-based wireless communicator.
“We welcome the next-generation Latitude NXT system as it provides pacemaker patients with a simple and easy-to-use communicator that may replace certain in-clinic follow-up visits. The system offers clinicians the most comprehensive suite of diagnostic tools in the CRM [cardiac rhythm management] industry to support proactive treatment decisions and provide an opportunity to verify improvement of clinical outcomes, as was demonstrated for ICD [implantable cardioverter defibrillator] and CRT-D [cardiac resychronization therapy defibrillator] patients in the ALTITUDE Survival study,” said Verlato.
The Latitude NXT website and patient communicator merge key features from the Latitude system with new features requested by physicians and patients, and is fully compatible with Boston Scientific’s advanced pacemaker family: Ingenio and Advantio pacemakers and INVIVE cardiac resynchronization therapy pacemakers (CRT-P).
Latitude NXT offers patients a simplified experience with wireless and automatic remote follow-up and optional integrated cellular GSM connectivity, providing patients with greater convenience than existing systems. In addition, it features a unique communicator-initiated device interrogation which is designed to minimize impact on implanted device battery longevity, potentially giving patients greater peace of mind.
Latitude NXT offers health care professionals a system that provides convenient online access to relevant pacemaker patient information, and flexibility and control in how clinicians receive and review data. The system features alert notification options such as SMS message or email, simple website administration, and integration with the electronic medical records (EMR) to automate hospital workflow — which could save up to 15 minutes for each patient transmission, the average time it takes to manually enter routine device follow-up data into an EMR system.
Latitude NXT is compatible with the wireless weight scale and blood pressure monitor from Boston Scientific. Physicians can choose to remotely monitor a series of relevant health status indicators including weight and blood pressure, as well as respiratory and sleep apnea trending. By providing access to this diagnostic information, Latitude NXT enables physicians to risk-stratify patients to more confidently make informed, proactive treatment decisions.
Pacemakers are designed to treat bradycardia, a condition in which the heart beats too slowly – usually less than 60 beats per minute – depriving the body of sufficient oxygen.
The Latitude NXT remote patient management system is currently under review by the U.S. Food and Drug Administration and is currently not available for sale in the United States.
For more information: www.bostonscientific.com
More like this
- Boston Scientific Ingenio Pacemakers Receive European Clearance for Use in MRI Scans
- FDA Clears New Boston Scientific Devices to Treat Bradycardia
- Boston Scientific Launches Ingenio Pacemakers in Europe
- Boston Scientific Begins Clinical Trial To Evaluate New Pacing System in MRI Environment
- Patient Management System Cleared for ICD, CRT-D Use